Literature DB >> 22156223

Optimization of fluorescently labeled Nrf2 peptide probes and the development of a fluorescence polarization assay for the discovery of inhibitors of Keap1-Nrf2 interaction.

Daigo Inoyama1, Yu Chen, Xinyi Huang, Lesa J Beamer, Ah-Ng Tony Kong, Longqin Hu.   

Abstract

Activation of the antioxidant response element (ARE) upregulates enzymes involved in detoxification of electrophiles and reactive oxygen species. The induction of ARE genes is regulated by the interaction between redox sensor protein Keap1 and the transcription factor Nrf2. Fluorescently labeled Nrf2 peptides containing the ETGE motif were synthesized and optimized as tracers in the development of a fluorescence polarization (FP) assay to identify small-molecule inhibitors of the Keap1-Nrf2 interaction. The tracers were optimized to increase the dynamic range of the assay and their binding affinities to the Keap1 Kelch domain. The binding affinities of Nrf2 peptide inhibitors obtained in our FP assay using FITC-9mer Nrf2 peptide amide as the probe were in good agreement with those obtained previously by a surface plasmon resonance assay. The FP assay exhibits considerable tolerance toward DMSO and produced a Z' factor greater than 0.6 in a 384-well format. Further optimization of the probe led to cyanine-labeled 9mer Nrf2 peptide amide, which can be used along with the FITC-9mer Nrf2 peptide amide in a high-throughput screening assay to discover small-molecule inhibitors of Keap1-Nrf2 interaction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22156223      PMCID: PMC3309107          DOI: 10.1177/1087057111430124

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  37 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

2.  Fluorescence polarization competition assay: the range of resolvable inhibitor potency is limited by the affinity of the fluorescent ligand.

Authors:  Xinyi Huang
Journal:  J Biomol Screen       Date:  2003-02

3.  Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex.

Authors:  Donna D Zhang; Shih-Ching Lo; Janet V Cross; Dennis J Templeton; Mark Hannink
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

4.  Crystallization and initial crystallographic analysis of the Kelch domain from human Keap1.

Authors:  Xuchu Li; Donna Zhang; Mark Hannink; Lesa J Beamer
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

5.  Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling.

Authors:  Shih-Ching Lo; Xuchu Li; Michael T Henzl; Lesa J Beamer; Mark Hannink
Journal:  EMBO J       Date:  2006-08-03       Impact factor: 11.598

6.  A fluorescence polarization based Src-SH2 binding assay.

Authors:  B A Lynch; K A Loiacono; C L Tiong; S E Adams; I A MacNeil
Journal:  Anal Biochem       Date:  1997-04-05       Impact factor: 3.365

Review 7.  Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution.

Authors:  Keiko Taguchi; Hozumi Motohashi; Masayuki Yamamoto
Journal:  Genes Cells       Date:  2011-02       Impact factor: 1.891

Review 8.  Nrf2 as a target for cancer chemoprevention.

Authors:  Xiang Yu; Thomas Kensler
Journal:  Mutat Res       Date:  2005-07-28       Impact factor: 2.433

Review 9.  Integration and diversity of the regulatory network composed of Maf and CNC families of transcription factors.

Authors:  Hozumi Motohashi; Tania O'Connor; Fumiki Katsuoka; James Douglas Engel; Masayuki Yamamoto
Journal:  Gene       Date:  2002-07-10       Impact factor: 3.688

10.  Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain.

Authors:  K Itoh; N Wakabayashi; Y Katoh; T Ishii; K Igarashi; J D Engel; M Yamamoto
Journal:  Genes Dev       Date:  1999-01-01       Impact factor: 11.361

View more
  30 in total

Review 1.  Non-electrophilic modulators of the canonical Keap1/Nrf2 pathway.

Authors:  B G Richardson; A D Jain; T E Speltz; T W Moore
Journal:  Bioorg Med Chem Lett       Date:  2015-04-16       Impact factor: 2.823

2.  Fluorescence polarization assays in high-throughput screening and drug discovery: a review.

Authors:  Matthew D Hall; Adam Yasgar; Tyler Peryea; John C Braisted; Ajit Jadhav; Anton Simeonov; Nathan P Coussens
Journal:  Methods Appl Fluoresc       Date:  2016-04-28       Impact factor: 3.009

Review 3.  Small molecules inhibiting Keap1-Nrf2 protein-protein interactions: a novel approach to activate Nrf2 function.

Authors:  Chunlin Zhuang; Zhongli Wu; Chengguo Xing; Zhenyuan Miao
Journal:  Medchemcomm       Date:  2016-11-17       Impact factor: 3.597

4.  Interaction Energetics and Druggability of the Protein-Protein Interaction between Kelch-like ECH-Associated Protein 1 (KEAP1) and Nuclear Factor Erythroid 2 Like 2 (Nrf2).

Authors:  Mengqi Zhong; Andrew Lynch; Samantha N Muellers; Stefan Jehle; Lingqi Luo; David R Hall; Reina Iwase; James P Carolan; Megan Egbert; Amanda Wakefield; Kristina Streu; Christine M Harvey; Paula C Ortet; Dima Kozakov; Sandor Vajda; Karen N Allen; Adrian Whitty
Journal:  Biochemistry       Date:  2020-01-02       Impact factor: 3.162

5.  Engineering a genetically encoded competitive inhibitor of the KEAP1-NRF2 interaction via structure-based design and phage display.

Authors:  Gurkan Guntas; Steven M Lewis; Kathleen M Mulvaney; Erica W Cloer; Ashutosh Tripathy; Thomas R Lane; Michael B Major; Brian Kuhlman
Journal:  Protein Eng Des Sel       Date:  2015-10-20       Impact factor: 1.650

6.  Activation of NRF2 Signaling in HEK293 Cells by a First-in-Class Direct KEAP1-NRF2 Inhibitor.

Authors:  Xia Wen; Gabriell Thorne; Longqin Hu; Melanie S Joy; Lauren M Aleksunes
Journal:  J Biochem Mol Toxicol       Date:  2015-02-12       Impact factor: 3.642

7.  NRF2-targeted therapeutics: New targets and modes of NRF2 regulation.

Authors:  Montserrat Rojo de la Vega; Matthew Dodson; Eli Chapman; Donna D Zhang
Journal:  Curr Opin Toxicol       Date:  2016-10-12

8.  Development of a Cell-Permeable Cyclic Peptidyl Inhibitor against the Keap1-Nrf2 Interaction.

Authors:  Heba Salim; Jian Song; Ashweta Sahni; Dehua Pei
Journal:  J Org Chem       Date:  2019-10-28       Impact factor: 4.354

9.  Synthesis and Evaluation of Noncovalent Naphthalene-Based KEAP1-NRF2 Inhibitors.

Authors:  Phillip R Lazzara; Atul D Jain; Amanda C Maldonado; Benjamin Richardson; Kornelia J Skowron; Brian P David; Zamia Siddiqui; Kiira M Ratia; Terry W Moore
Journal:  ACS Med Chem Lett       Date:  2020-02-19       Impact factor: 4.345

10.  Polar Recognition Group Study of Keap1-Nrf2 Protein-Protein Interaction Inhibitors.

Authors:  Meng-Chen Lu; Shi-Jie Tan; Jian-Ai Ji; Zhi-Yun Chen; Zhen-Wei Yuan; Qi-Dong You; Zheng-Yu Jiang
Journal:  ACS Med Chem Lett       Date:  2016-07-05       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.